The drug, called Kisqali (ribociclib), is already approved for treating such patients -- based on earlier results showing it can delay the progression of their cancer.
from WebMD Health https://wb.md/2Wl7XWt
International Medical News Latest health News ,health tips health and wellness health news health and fitness health style
The drug, called Kisqali (ribociclib), is already approved for treating such patients -- based on earlier results showing it can delay the progression of their cancer.
0 Comments:
Post a Comment